Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1861 1
1866 1
1868 2
1871 2
1872 1
1873 2
1874 1
1876 1
1877 1
1881 1
1882 2
1883 1
1884 2
1885 2
1886 1
1887 1
1892 1
1918 1
1920 1
1921 2
1922 2
1923 2
1926 2
1927 1
1928 1
1929 1
1930 1
1931 1
1932 1
1934 1
1937 1
1938 1
1940 1
1945 1
1946 1
1949 4
1950 4
1951 3
1952 1
1954 5
1955 2
1956 1
1957 1
1958 4
1959 2
1960 4
1961 3
1962 1
1963 4
1964 2
1965 2
1966 6
1967 4
1968 10
1969 9
1970 6
1971 3
1972 3
1973 8
1974 3
1975 4
1976 4
1977 12
1978 15
1979 12
1980 6
1981 6
1982 16
1983 15
1984 11
1985 12
1986 21
1987 14
1988 17
1989 26
1990 25
1991 16
1992 6
1993 16
1994 10
1995 8
1996 20
1997 13
1998 14
1999 12
2000 13
2001 19
2002 24
2003 15
2004 33
2005 35
2006 31
2007 49
2008 45
2009 43
2010 67
2011 66
2012 65
2013 71
2014 74
2015 81
2016 75
2017 84
2018 111
2019 83
2020 93
2021 122
2022 114
2023 117
2024 87

Text availability

Article attribute

Article type

Publication date

Search Results

1,902 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Practice Guideline to Improve Locomotor Function Following Chronic Stroke, Incomplete Spinal Cord Injury, and Brain Injury.
Hornby TG, Reisman DS, Ward IG, Scheets PL, Miller A, Haddad D, Fox EJ, Fritz NE, Hawkins K, Henderson CE, Hendron KL, Holleran CL, Lynskey JE, Walter A; and the Locomotor CPG Appraisal Team. Hornby TG, et al. Among authors: fox ej. J Neurol Phys Ther. 2020 Jan;44(1):49-100. doi: 10.1097/NPT.0000000000000303. J Neurol Phys Ther. 2020. PMID: 31834165 Review.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. Among authors: fox e. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Interventions to prevent miscarriage.
Dhillon-Smith RK, Melo P, Kaur R, Fox E, Devall A, Woodhead N, Coomarasamy A. Dhillon-Smith RK, et al. Among authors: fox e. Fertil Steril. 2023 Nov;120(5):951-954. doi: 10.1016/j.fertnstert.2023.08.955. Epub 2023 Aug 28. Fertil Steril. 2023. PMID: 37648141 Review.
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O'Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G; PROPPR Study Group. Holcomb JB, et al. Among authors: fox ee. JAMA. 2015 Feb 3;313(5):471-82. doi: 10.1001/jama.2015.12. JAMA. 2015. PMID: 25647203 Free PMC article. Clinical Trial.
Detection of ultra-rare mutations by next-generation sequencing.
Schmitt MW, Kennedy SR, Salk JJ, Fox EJ, Hiatt JB, Loeb LA. Schmitt MW, et al. Among authors: fox ej. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14508-13. doi: 10.1073/pnas.1208715109. Epub 2012 Aug 1. Proc Natl Acad Sci U S A. 2012. PMID: 22853953 Free PMC article.
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
Traboulsee A, Greenberg BM, Bennett JL, Szczechowski L, Fox E, Shkrobot S, Yamamura T, Terada Y, Kawata Y, Wright P, Gianella-Borradori A, Garren H, Weinshenker BG. Traboulsee A, et al. Among authors: fox e. Lancet Neurol. 2020 May;19(5):402-412. doi: 10.1016/S1474-4422(20)30078-8. Lancet Neurol. 2020. PMID: 32333898 Free PMC article. Clinical Trial.
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, Whipple NS, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki MS, Armstrong AE, Cash T, Pratilas CA, Corradini N, Marshall LV, Farid-Kapadia M, Chohan S, Devlin C, Meneses-Lorente G, Cardenas A, Hutchinson KE, Bergthold G, Caron H, Chow Maneval E, Gajjar A, Fox E. Desai AV, et al. Among authors: fox e. Neuro Oncol. 2022 Oct 3;24(10):1776-1789. doi: 10.1093/neuonc/noac087. Neuro Oncol. 2022. PMID: 35395680 Free PMC article. Clinical Trial.
Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, Salner AL, Schauer PK, Joshi P, Fox E, Shin DG, Weinstock GM, Strausbaugh LD, Dongari-Bagtzoglou A, Peterson DE, Diaz PI. Hong BY, et al. Among authors: fox e. Microbiome. 2019 Apr 25;7(1):66. doi: 10.1186/s40168-019-0679-5. Microbiome. 2019. PMID: 31018870 Free PMC article.
1,902 results